Remember the backlog at the Administrative Law Judge (ALJ) level of review? Where providers routinely waited years for hearings, while recoupments proceeded and cash flow deteriorated? Eventually, after many complaints, as you may know, the government hired over 80 new ALJs and shortened processing times, alleviating what had become the most notorious bottleneck in the system.
As frequently occurs in complex regulatory schemes, however, the problem did not disappear; it simply migrated. Today, providers increasingly encounter prolonged delays not before the ALJ level, but after it, at the fourth level of appeal before the Medicare Appeals Council, which operates within the Departmental Appeals Board of the U.S. Department of Health and Human Services (HHS). While this shift initially may appear to be merely a relocation of the same systemic inefficiency, delay at the Council level presents a materially different legal landscape – and, counterintuitively, often places providers in a stronger strategic position than delays earlier in the administrative process.
What does that mean? This is fantastic for providers.
Unlike in earlier stages of appeal, where timeframes may feel aspirational in practice, the governing regulations impose a clear and mandatory adjudication deadline on the Council. Under 42 C.F.R. § 405.1100(c), the Council must issue a decision, dismissal, or remand within 90 calendar days of receiving a request for review. The regulation does not characterize this period as discretionary or subject to generalized workload considerations; rather, it establishes a defined adjudication window that reflects the expectation that Council review will be prompt. Nevertheless, many providers now report Council matters remaining pending for six months, nine months, or longer, substantially exceeding the regulatory timeframe. But you can escalate! Don’t accept the slow decision-making!
Importantly, Council delay is not merely an administrative inconvenience. The regulations expressly recognize that prolonged inaction at this stage should not trap appellants indefinitely. To address this concern, the Centers for Medicare & Medicaid Services (CMS) created a formal escalation mechanism that permits providers to exit the administrative system entirely when the Council fails to act within the prescribed period. Specifically, 42 C.F.R. § 405.1132 permits an appellant to seek escalation to federal district court once the Council acknowledges that it cannot issue a timely decision. Upon receipt of that acknowledgment, the provider may file suit in federal court and obtain judicial review of the claim without waiting for a final agency determination.
This regulatory framework has significant strategic implications. By the time a case reaches the Council, the appeal has already progressed through redetermination, reconsideration, and a full evidentiary hearing before an ALJ. The administrative record is therefore largely complete, typically including documentary exhibits, witness testimony, expert analysis, and developed legal arguments. Because judicial review in Medicare reimbursement disputes is generally confined to the administrative record, escalation at the Council stage does not disadvantage the provider in terms of evidentiary development. To the contrary, it allows the provider to present a fully formed record to an independent federal judge, rather than continuing to seek relief within the same agency structure that initiated the recoupment.
Federal district court review offers several additional advantages. First, the decision-maker is independent from CMS and its contractors, which enhances both the perception and the reality of neutrality. Second, courts are particularly well-suited to address legal and procedural issues that frequently arise in Medicare disputes, including statutory interpretation, compliance with regulatory requirements, due-process concerns, improper extrapolation methodologies, and the agency’s reliance on sub-regulatory guidance. Third, the prospect of federal litigation often alters the government’s settlement posture, as the risks associated with adverse precedent, published opinions, and judicial scrutiny may encourage earlier and more pragmatic resolution.
For these reasons, a backlog at the Council level is different from the historic ALJ backlog. Whereas ALJ delays effectively prevented providers from reaching an independent forum, Council delays may accelerate that outcome by triggering the right to escalate. In many such circumstances, consider doing so on the 91st day! It is often in your best interest!
In this sense, the regulatory scheme transforms agency inaction into a procedural advantage for appellants who understand and utilize the escalation process.
From a practical standpoint, providers and their counsel should treat the Council stage as a pre-litigation phase, rather than a period of passive waiting. Counsel should carefully calendar the date the request for Council review is filed and calculate the 90-day adjudication deadline established by 42 C.F.R. § 405.1100. During that period, the focus should be on ensuring that the administrative record is complete, that legal theories are clearly articulated, and that the case is positioned for potential judicial review. If the Council fails to issue a timely decision, the provider should promptly pursue escalation under 42 C.F.R. § 405.1132, rather than allowing additional months of delay to accrue.
In sum, while the migration of Medicare appeal delays from the ALJ level to the Medicare Appeals Council is understandably frustrating, it does not leave providers without recourse. To the contrary, the governing regulations provide a clear path out of administrative limbo and into federal court, where disputes can be resolved by an independent judiciary applying traditional principles of administrative and statutory law. Providers who recognize this opportunity and plan accordingly may find that a post-ALJ backlog, rather than prolonging uncertainty, can become the most direct route to meaningful judicial review and timely resolution of their claims.
EDITOR’S NOTE:
The opinions expressed in this article are solely those of the author and do not necessarily represent the views or opinions of MedLearn Media. We provide a platform for diverse perspectives, but the content and opinions expressed herein are the author’s own. MedLearn Media does not endorse or guarantee the accuracy of the information presented. Readers are encouraged to critically evaluate the content and conduct their own research. Any actions taken based on this article are at the reader’s own discretion.



















